Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Life Members Life Members & Contact Bharat B. AGGARWAL, Ph.D. (U.C., Berkeley) UT M. D. Anderson Cancer Center Houston, TX aggarwal@mdanderson.org Research Interest & Hobbies Inflammation and cancer, cytokines, NFkβ Dr. Ram P. AGARWAL Professor University of Miami Medical Center Miami, FL RAgarwal@med.miami.edu Krishna C. AGRAWAL, Ph.D. (Deceased) Regents Professor and Chairman Department of Pharmacology Tulane University School of Medicine New Orleans, LA 70112 Thiru ARUMUGAM, Ph.D. Senior Research Scientist Dept of Cancer Biology UT MD Anderson Cancer Center, Houston, TX77030 Tarumugam@mdanderson.org; athiruvengadam@yahoo.com Dr. Shilpi ARORA Scientist Constellation Pharmaceuticals Boston, MA ssoniarora@gmail.com Dr. Shubha BAGRODIA Scientist Pfizer San Diego, CA Shubha.bagrodia@pfizer.com Dr. Hamid BAND Elizabeth Bruce Professor of Cancer Research at Eppley Institute, and associate director of translational research at the Fred & Pamela Buffett Cancer Center University of Nebraska Medical Center Omaha, NE hband@unmc.edu Research Interests: Pancreatic Cancer, Chemoresistance, Bioinformatics Hobbies: Reading, Music Dr. Vimla BAND Ardith & Anna Von Housen Professor Chair, Department of Genetics, Cell Biology & Anatomy Associate Director of Center for Breast Cancer Research Fred & Pamela Buffett Cancer Center University of Nebraska Medical Center Omaha, NE Delineate molecular mechanisms of early steps in transformation of mammary epithelial cells with the goal of identifying novel molecular diagnostic/prognostic markers and potential Cancer genetics Regulation of tyrosine kinase-mediated cell signaling with the longterm goal of developing targeted therapeutics and early diagnostic/prognostic markers for cancer vband@unmc.edu Dr. Prashant BAVI, M.D. Postdoctoral Fellow Dept Of Human Cancer Genomic Research prashantbavi1@rediffmail.com; pbavi@kfshrc.edu.sa Website: http://www.linkedin.com/in/prashantbavi Dr. Subhash CHAKRABARTY Professor Depart. of Microbiology, Immunology & Cell Biology Simmons Cooper Cancer Institute Southern Illinois University School of Medicine Springfield, Illinois 62794‐9677 schakrabarty@siumed.edu Dr. Dhrubajyoti CHAKRAVARTI, Ph.D. Chief Scientist 4115 Harrison St, Bellevue, NE 68147 dhruba@gogeneguard.com Website: http://www.life-120.com/ Dhyan Chandra, Ph.D. (JNU, India) Assistant Professor Dept. of Pharmacology & Therapeutics Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY14263 Dhyan.chandra@roswellpark.org Chandradhar DWIVEDI, Ph.D. (Lucknow University) Distinguished Professor and Head, Department of Pharmaceutical Sciences College of Pharmacy, South Dakota State University, Brookings, SD 57007 Chandradhar.Dwivedi@sdstate.edu Dr. Bakul I. DALAL, M.D., FRCP Hematopathologist Vancouver General Hospital Clinical Professor, University of British Columbia Vancouver Coastal Health 11Th Floor 601 West Broadway Vancouver, British Columbia V5Z 4C2 Canada bakul.dalal@vch.ca Dr. Rama S. DWIVEDI Northwestern University Chicago, IL ramaa@northwestern.edu therapy targets of breast cancers Research Interests Oncopathology: Colorectal Cancer and Thyroid Cancer, validation of biomarkers, improving efficacy of tissue microarray technology, Image analysis, and tumor biobanking Mechanisms of growth and differentiation control in epithelial cancer. Research Interests: Identify and develop natural and synthetic compounds that provide protection against environmental pollution. Hobbies: Photography Research Interest: Apoptosis signaling, cancer stem cells Research InterestCancer prevention and treatment Hobbies- Reading, spirituality, listening to music, gardening Hematopathology Dr. Sanjiv Sam GAMBHIR Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research Chair, Department of Radiology Stanford University School of Medicine Stanford, CA sgambhir@stanford.edu Dr. Varsha GANDHI Department of Experimental Therapeutics UT M.D. Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030 vgandhi@mdanderson.org Dr. Aniruddha GANGULY National Cancer Institute Bethesda, MD aganguly@comcast.net Dr. Ramesh GANJU Scott Endowed Chair and Professor Vice Chair, Experimental Pathology 810 Biomedical Research Tower 460 West 12th Avenue Columbus, OH 43210 ramesh.ganju@osumc.edu Dr. Rita GHOSH Assistant Professor Department of Urology The University of Texas Health Science Center at San Antonio 7703 Floyd Curl Drive, Mail Code 7845 San Antonio, Texas 78229-3900 Phone: (210) 567-5664 ghoshr@uthscsa.edu Dr. Rayudu GOPALKRISHNA Associate Professor Cell and Neurobiology Keck School of Medicine University of Southern California Health Sciences Camous Los Angeles, CA 90089-9112 rgopalak@usc.edu Dr. Sushovan GUHA, M.D., Ph.D. Gastroenterologist The University of Texas Health Sciences Center at Houston Medical School 6411 Fannin St, Houston, TX 77030 Phone: (713) 704-4000 Dr. Rishab K. GUPTA Wayne Cancer Institute, CA Gupta@jwci.org Radiology/Nuclear Medicine Experimental therapeutics Mechanisms of tumor development & metastasis, tumor microenvironment, brain tumor biology, cancer diagnostics, molecular analysis technologies Role of chemokines, and various inflammatory molecules, and anti-inflammatory molecules, in pathogenesis of various diseases Study on deregulation of DNA damage signaling and cell cycle progression in cancer and use these pathways as molecular targets to develop strategies for cancer prevention and or therapy Prostate cancer prevention Research Interests: Novel signal transduction pathways in GI cancers and chemoprevention of GI cancer Dr. Shanker L. GUPTA Program Manager Developmental Therapeutics Program Division of Cancer Treatment and Diagnosis National Cancer Institute Bethesda, MD shanker.gupta@nih.gov Dr. Sudhir GUPTA, M.D. Professor sgupta@uci.edu Anti-cancer drug development Dr. Surendra GUPTA, Ph.D. President American Radiolabeled Chemicals, Inc. Email: drgupta@arc-inc.com Website: www.arc-inc.com Radiopharmaceuticals Molecular signaling in apoptosis Memory CD4+ and CD8+ T cells Dendritic cell functions Dr. Abid HUSSAIN Dr. H.N. JAYARAM Professor Indiana University, IN hjayaram@iupui.edu Dr. Anil K. JAISWAL Professor Department of Pharmacology Howard Hall, 404 University of Maryland School of Medicine Baltimore, MD ajaiswal@som.umaryland.edu Dr. Madhavi KADAKIA 122 Diggs Laboratory Dept. of Biochemistry & Molecular Biology Wright State University Dayton, OH 45435 madhavi.kadakia@wright.edu Dr. Hari KAUL, Ph.D., FACN, FACN Carroll W. Feist Endowed Chair Professor & Chairman Department of Biochemistry & Molecular Biology School of Medicine LSUHSC- shreverport, LA Associate Director, Feist Weiller Cancer Center Phone (office):318-675-5161 hkoul@lsuhsc.edu Oxidative stress signaling with a focus on Nrf2:INrf2 (Keap1) signaling; cell survival and death; chemoprevention; oncogenesis with focus on hematological malignancies, skin, breast and prostate cancer, and metastasis; drug resistance; and bioreductive drug development. Dr. Meena KATDARE, (University of Pune, India, 1978) Director, Carcinogenesis and Chemoprevention Laboratory Weill Cornell Medical College 1300 York Avenue, Box-287, New York, NY 10021 Ph: 212-746-5431 - msk2004@med.cornell.edu http://www.cornellsurgery.org/pro/research/biosketch es.html Dr. Koyamangalath KRISHNAN, MD, FRCP, FACP Dishner Endowed Chair of Excellence in Medicine Professor of Medicine Division Chief of Hematology/Oncology Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, The UT MD Anderson Cancer Center, Houston, TX 77030 krishnak@etsu.edu Dr. Raju KUCHERLAPATI Paul C. Cabot Professor, Department of Genetics, Harvard Medical School Professor, Department of Medicine Scientific Director, Harvard-Partners Center for Genetics and Genomics, Partners HealtheCare System, Brigham And Women's Hospital Boston, MA RKUCHERLAPATI@PARTNERS.ORG Dr. Rakesh KUMAR Birch & McCormick Chair Catharine Birch and William P. McCormick Chair of Biochemistry and Molecular Biology Professor George Washington University School of Medicine Washington, DC bcmrxk@gwu.edu Dr. Shaji KUMAR, (M.D.) Associate Professor Mayo Clinic, Rochester, MN 55905 kumar.shaji@mayo.edu Research Interests: Signal transduction pathways of carcinogenesis and chemoprevention of breast, colon, prostate and thyroid cancers Hobbies: Gardening, Interior Decoration, Knitting, Dress designing, Travel, Indian Music Cloning and characterization of human disease genes with a focus on human syndromes with a significant cardiovascular involvement; use of genetic/genomic approaches to understand the biology of cancer and the generation and characterization of genetically modified mouse models for cancer and other human disorders. Research Interests: Interactions between malignant plasma cells and the marrow microenvironment in plasma cell malignancies; develop new therapeutic approaches to target these interactions and enhance the efficacy of the currently available therapies. Dr. Aroop MANGALIK, M.D. Hematology 900 Camino de Salud NE 1 University of New Mexico Albuquerque, NM 87131 Dr. Kapil MEHTA, (Ph.D., PGI, Chandigarh, India) Professor of Cancer Medicine (Biochemistry) Univ of Texas M. D. Anderson Cancer Center Houston, TX 77030 (http://www.mdanderson.org/departments/expther/) Email: kapilmeh@gmail.com Research interests: Chemoresistance, metastasis, retinoids, drug delivery systems Hobbies: Reading, gardening, music Rajendra G. MEHTA, Ph.D. Assistant Vice President, Professor and Head IIT Research Institute and IIT Chicago, IL 60616 Rmehta@iitri.org Research Interests: Efficacy and molecular mechanism(s) of action of chemopreventive agents including Vitamin D and Resveratrol in breast, colon and lung cancer models. Dr. Krishna MENON Scientist/Business owner Cell Centix Inc. Beverly, MA menon@kardinc.com Dr. Lopa MISHRA (M.D.) Chair, Gastroenterology, Hepat. & Nutrition MD Anderson Cancer Center 1515 Holcombe Blvd Houston, TX 77030 Email: lmishra@mdanderson.org In vivo and vitro preclinical testing Dr. Debasish MONDAL Associate Professor Department of Pharmacology Tulane University New Orleans, LA dmondal@tulane.edu HIV-1 induced pathogenesis; role of HIV-1 transactivator (Tat) protein in regulating viral latency and infectivity; pharmacological interventions to enhance efficacy and reduce toxic side effects of antiretroviral drugs Gastroenterology Dr. Hasan MUKHTAR Professor Department of Dermatology University of Wisconsin School of Medicine & Public Health Madison, WI hmukhtar@dermatology.wisc.edu Molecular target based approaches for prevention and treatment of cancer and skin disease psoriasis by phytochemicals Dr. Anuradha MURALI Microbiology and Immunology Medical University of South Carolina Charleston, USA muraliak@musc.edu Dr. Harikrishna NAKSHATRI Marian J. Morrison Professor of Surgery Indiana University School of Medicine Indianapolis, IN hnakshat@iupui.edu Dr. Pratima NANGIA-MAKKER Assistant Professor Wayne State University, Detroit, MI 48201 makkerp@karmanos.org Dr. Satyabrata NANDI Professor Emeritus of Cell & Developmental Biology University of California, Berkeley, CA nandi@berkeley.edu Dr. Shanker NAYAK (Diseased) Director, Diagnostics Hoag Cancer Center New Port Beach, CA Activation of NF-kB in estrogen receptor negative breast cancer. The focus is on genomic aspects of anti-estrogen resistance, mechanisms of organ-specific metastasis and biomarkers of breast cancer progression and therapeutic response Research Interests: Role of carbohydratebinding protein galectin-3 in cancer progression and metastasis. We are also studying the inhibitory effects of natural plant products on cancer progression Determine the biological and molecular bases for susceptibility and resistance to breast carcinogenesis as well as for the prevention of breast cancer Gene vaccine therapy, Preclinical cancer research Dr. Arokya Mary S. PAPU JOHN Postdoctoral Research Associate Biomedical & Diagnostic Sciences University of Tennessee Knoxville, TN sashisebin@gmail.com Cancer Diagnostics Dr. Sen PATHAK Professor Cytogenetics MD Anderson cancer Center Houston, TX spathak@mdanderson.org Cancer cytogenetics Dr. Subbarayan R POCHI (Ph.D., Banaras Hindu University, 1994) Research Assistant Professor Department of Medicine Division of Hematology and Oncology University of Miami Miller School of Medicine Miami, FL - 33176 Research Interests: 5FU resistance, Pharmocogenomics, Ethno botanicals Hobbies: Reading, Traveling by road, Community work. Dr. Raj PURI, M.D., Ph.D. Division Director, Food and Drug Administration, Bethesda, MD Research Interests: puri@cber.fda.gov Dr. Govind RAGUPATHI Associate Attending Immunologist Memorial Sloan-Kettering Cancer Center New York, NY 10065 Tel: (646) 888 2363 Fax: (646) 422 0516 E-mail: ragupatg@mskcc.org Develop monoclonal antibodies, optimize vaccines that induce antibody responses, and produce and test new immunological adjuvants to augment these responses Dr. Ranju RALHAN Department of Pathology and Laboratory Medicine Joseph & Wolf Lebovic Health Complex Mt. Sinai Hospital 600 University Ave., Room 6-416 Toronto, ON M5G 1X5 ralhanr@gmail.com Translational cancer research, molecular diagnostics proteomics, genomics, epigenomics, cancer biology, cell biology, targeted therapy Dr. Chandra RAMANATHAN, Ph.D., MBA Scientist, Head Early Pipeline Oncology Bayer HealthCare Pharmaceuticals West Haven, Connecticut 06516 Chandra.ramanathan@bayer.com Dr. Aramandla RAMESH Associate Professor Biochemistry & Cancer Biology Meharry Medical College Nashville, TN aramesh@mmc.edu Environmental Toxicology, Chemical Carcinogenesis Dr. Kaladhar B. REDDY Professor Wayne State University School of Medicine 540 East Canfield Avenue Detroit, MI 48201 kreddy@med.wayne.edu Novel strategies for treatment and prognosis of breast cancer by combining experimental therapeutics with cell biology; cancer stem cells Dr. Shrikanth REDDY Department of GI Med Oncology MD Anderson Cancer Center 1515 Holcombe Blvd Box 0956 Houston, TX 77030 sareddy@mdanderson.org Dr. Fazlul SARKAR Distinguished Professor Department of Pathology Karmanos Cancer Institute Detroit, MI sarkarf@karmanos.org Dr. D. S. R. SARMA Professor University of Toronto, Canada sarma.dittakavi@utoronto.ca Dr. Neeraj SAXENA Assistant Professor University of Maryland School of Medicine Baltimore, MD nsaxena@medicine.umaryland.edu Dr. Senthamil SELVAN Vice-President R&D Omni Array Biotechnology 15601 Crabbs Branch Way Rockville, MD senthamils59@gmail.com Dr. Subrata SEN Professor & Deputy Chair, Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Phone: (713) 834-6040 Email: ssen@mdanderson.org Role of NF-κB and its signaling molecules in solid tumors, and in elucidating the molecular mechanisms of action of “natural agents” for cancer prevention and therapy Links between obesity, adipocytokines and carcinogenesis Cancer Immunotherapy Functional characterization of the genes regulating mitotic chromosome segregation and elucidation of their role in the induction of chromosomal instability in cancer Dr. Shyam SHARAN Deputy Program Director, Mouse Cancer Genetics Prog. Senior Investigator Head, Genetics of Cancer Susceptibility Section Center for Cancer Research National Cancer Institute, Frederick, MD sharans@mail.nih.gov Dr. Dipali SHARMA Associate Professor of Oncology Kimmel Cancer Center Johns Hopkins University Baltimore, MD dsharma7@jhmi.edu DNA repair, hereditary Breast cancer, tumor suppressor, mouse models, recombineering, BRCA1/2 variants Breast Cancer, ObesityCancer Connection, Adipocytokines, Metastasis, Tamoxifen Resistance, Novel Therapeutics, Bioactive Food Components, Signaling Mechanisms Dr. Zahid H. SIDDIK Scientist UTMD Anderson Cancer Center Houston, TX zsiddik@mdanderson.org Dr. Promila SINGH Professor Department of Biochemistry & Molecular Biology University of Texas Medical Branch Galveston, TX posingh@utmb.edu Dr. Sujay SINGH President and CEO ABGENEX Corp. San Diego, CA ssingh@abgenex.com Cancer diagnostics, Biotechnology development Dr. Anant SHRIKANT Professor of Molecular and Integrative Physiology and Surgery University of Kansas Medical Center Kansas sanant@kumc.edu Interest in understanding the mechanisms that regulate gene expression at the posttranscriptional levels of mRNA stability and translation during tumorigenesis Research Interest: Rol e of mitochondria in cancer, Inter genomic crosstalk and its role tumorigenesi s and mitochondrial diseases Hobbies: Kite flying, traveling Dr. Keshav K. SINGH Professor of Oncology Roswell Park Cancer Institute Buffalo, NY, 14263 www.keshavsingh.org Dr. Raghu SINHA (Ph.D., PGIMER, Chandigarh, India) Associate Professor Penn State College of Medicine, Hershey, Pennsylvania Website link: http://fred.psu.edu/ds/retrieve/fred/investigator/rus15 rus15@psu.edu Dr. Taduru SREENATH Assistant Director, CPDR Basic Science Research Program, The Henry M. Jackson Foundation Research Assistant Professor of Surgery USUHS tsreenath@cpdr.org Research Interests: Breast cancer model systems, molecular mechanisms of prevention in breast and prostate cancers. Dr. Saraswati SUKUMAR Barbara B. Rubenstein Professor of Oncology Johns Hopkins University School of Medicine, Baltimore, MD21231 saras@jhmi.edu Research Interests: Discovery and study of molecular alterations in breast cancer. Methods and markers for early detection and prognosis. Cancer diagnostics Dr. Atul TANDON President & CEO NeoBiotechnologies, Inc. Union City, CA aktandon@gmail.com Dr. Rajeshwar Rao TEKMAL Carl J. Pauerstein Professor in Reproductive Research, Director, Division of Reproductive Research Department of Obstetrics and Gynecology University of Texas Health Science Center at San Antonio San Antonio, TX 78229-3900 Tel: 210-567-4930; Direct: 210-567-4935 TEKMAL@uthscsa.edu Dr. Nityanand T. TELANG Roswell Park Cancer Institute Buffalo, NY telangn@mail.rockefeller.edu Dr. T. J. THOMAS Professor R.W. Johnson Medical Center Rutgers University, NJ tthomastj@gmail.com thomastj@rwjms.rutgers.edu Dr. Ratna K. VADLAMUDI Professor Department of Obstetrics & Gynecology UTHSCSA, San Antonio, TX Vadlamudi@uthscsa.edu Ph. (210) 567-4930 Scientific interests focus on understanding molecular mechanisms underlying prostate cancer initiation and development using mouse models Role of hormones and growth factors and their receptors in the initiation and progression of breast, cervical and ovarian cancers. Develop novel DNA delivery vehicles for gene therapy. The current focus is on breast cancer Research Interests: Estrogen signaling, Hormonal therapy resistance, Nuclear receptors, Signal transduction, Tg/KO mouse models for cancer Dr. Hariprasad VANKAYALAPATI Scientist/Medicinal chemist Draper, UT hari@hci.utah.edu hari.medchem@gmail.com Dr. Atul VARADHACHARI, M.D. President & Chief Operating Officer Agennix, Inc., Houston, TX avaradhachary@agennix.com Dr. Arti PATEL VARANASI,, Ph.D., M.P.H. President & CEO Advancing Synergy, LLC 1450 South Rolling Road Baltimore, MD 21227 www.advancingsynergy.com avaranasi@advancingsynergy.com Siva VENUGOPAL Sugar Land, TX Engineering/bioinformatics company owner sivagsya@gmail.com Dr. Inder VERMA Professor Laboratory of Genetics American Cancer Society Professor of Molecular Biology Irwin and Joan Jacobs Chair in Exemplary Life Science The Salk Institute for Biological Studies La Jolla, CA verma@salk.edu Dr. Ajit K. VERMA (Univ of South Australia, Adelaide) Professor, University of Wisconsin Madison, WI 53792 weblink: www.med.wisc.edu/metc/fac/fac53.php. E-mail: akverma@facstaff.wisc.edu Dr. Meena VORA Scientist/Business owner Biosphare Fremont, CA mvora@biophase.net Cancer research, public health, advocacy, capacity building and project management Gene therapy for cancer; developed viruses for gene therapy vectors; developed a gene therapy vector, based on a strippeddown version of HIV, that can deliver genes to non-dividing cells, which constitute majority of the cells in our bodies. Research interests: etiology and prevention of skin and prostate cancer. PKCepsilon signal transduction pathways Hobbies: fishing and gardening. Dr. Mansukh WANI Principal Scientist (Retired) Research Triangle Institute, NC 27709 www.rti.org/naturalproducts mcw@rti.org Research Interests: Discovery of Anticancer Agents of Diverse Natural Origin